| Dr Gayatri Jaiswal, MD | |
|
1900 Waterdam Plaza Dr Ste 2, Canonsburg, PA 15317-5442 | |
| (724) 941-7490 | |
| (724) 941-5231 |
| Full Name | Dr Gayatri Jaiswal |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 16 Years |
| Location | 1900 Waterdam Plaza Dr Ste 2, Canonsburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376773275 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD472235 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Canonsburg General Hospital | Canonsburg, PA | Hospital |
| Allegheny General Hospital | Pittsburgh, PA | Hospital |
| Jefferson Hospital | Jefferson hills, PA | Hospital |
| West Penn Hospital | Pittsburgh, PA | Hospital |
| Washington Hospital, The | Washington, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allegheny Clinic | 5395649586 | 1941 |
News Archive
Scientists in Sweden are reporting for the first time that a group of drugs used to treat heart failure shows promise for fighting colon cancer. The study is in ACS' Journal of Natural Products, a monthly publication. Colon cancer is the third most common cancer in the United States, with more than 150,000 cases diagnosed in the U.S. each year.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, together with collaborators at the Massachusetts Institute of Technology (MIT), announced today the publication of new paper describing discovery of "core-shell" nanoparticles for systemic delivery of RNAi therapeutics.
In a new study posted to the medRxiv* server scientists from Weil Cornell University and Stony Brook University in New York attempted to identify the metabolic and immune markers associated with severe COVID-19 disease using high-throughput targeted nuclear magnetic resonance (NMR) spectroscopy and high-dimensional flow cytometry. This will facilitate risk stratification, monitoring, and therapeutic interventions in COVID-19 patients.
The BCR/ABL gene, which does not occur among healthy people, has been shown to be a causative agent in the pathogenesis of B-cell acute lymphocytic leukemia.
Indigenous people around the world are among the most vulnerable to climate change and are increasingly susceptible to the pathogen loads found in potable water after heavy rainfall or rapid snow melt.
› Verified 7 days ago
| Entity Name | Allegheny Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
Scientists in Sweden are reporting for the first time that a group of drugs used to treat heart failure shows promise for fighting colon cancer. The study is in ACS' Journal of Natural Products, a monthly publication. Colon cancer is the third most common cancer in the United States, with more than 150,000 cases diagnosed in the U.S. each year.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, together with collaborators at the Massachusetts Institute of Technology (MIT), announced today the publication of new paper describing discovery of "core-shell" nanoparticles for systemic delivery of RNAi therapeutics.
In a new study posted to the medRxiv* server scientists from Weil Cornell University and Stony Brook University in New York attempted to identify the metabolic and immune markers associated with severe COVID-19 disease using high-throughput targeted nuclear magnetic resonance (NMR) spectroscopy and high-dimensional flow cytometry. This will facilitate risk stratification, monitoring, and therapeutic interventions in COVID-19 patients.
The BCR/ABL gene, which does not occur among healthy people, has been shown to be a causative agent in the pathogenesis of B-cell acute lymphocytic leukemia.
Indigenous people around the world are among the most vulnerable to climate change and are increasingly susceptible to the pathogen loads found in potable water after heavy rainfall or rapid snow melt.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gayatri Jaiswal, MD 1900 Waterdam Plaza Dr Ste 2, Canonsburg, PA 15317-5442 Ph: (724) 941-7490 | Dr Gayatri Jaiswal, MD 1900 Waterdam Plaza Dr Ste 2, Canonsburg, PA 15317-5442 Ph: (724) 941-7490 |
News Archive
Scientists in Sweden are reporting for the first time that a group of drugs used to treat heart failure shows promise for fighting colon cancer. The study is in ACS' Journal of Natural Products, a monthly publication. Colon cancer is the third most common cancer in the United States, with more than 150,000 cases diagnosed in the U.S. each year.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, together with collaborators at the Massachusetts Institute of Technology (MIT), announced today the publication of new paper describing discovery of "core-shell" nanoparticles for systemic delivery of RNAi therapeutics.
In a new study posted to the medRxiv* server scientists from Weil Cornell University and Stony Brook University in New York attempted to identify the metabolic and immune markers associated with severe COVID-19 disease using high-throughput targeted nuclear magnetic resonance (NMR) spectroscopy and high-dimensional flow cytometry. This will facilitate risk stratification, monitoring, and therapeutic interventions in COVID-19 patients.
The BCR/ABL gene, which does not occur among healthy people, has been shown to be a causative agent in the pathogenesis of B-cell acute lymphocytic leukemia.
Indigenous people around the world are among the most vulnerable to climate change and are increasingly susceptible to the pathogen loads found in potable water after heavy rainfall or rapid snow melt.
› Verified 7 days ago
John F Smith Jr., MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 161 Waterdam Rd Apt 120, Canonsburg, PA 15317 Phone: 412-359-8900 Fax: 412-359-8977 | |
Elaine L Goldhammer, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Blvd, Canonsburg, PA 15317 Phone: 412-359-3030 Fax: 412-359-3060 | |
Euhan John Lee, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Blvd, Canonsburg, PA 15317 Phone: 724-873-5934 Fax: 724-873-5954 | |
Dr. Michael Grimes, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1900 Waterdam Plaza Dr Ste 2, Canonsburg, PA 15317 Phone: 724-941-7490 Fax: 724-941-5231 | |
Elina Salem, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Blvd, Canonsburg, PA 15317 Phone: 412-359-3030 | |
Dr. Patricio Andres Sanchez-cueva, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1447 Network Dr, Canonsburg, PA 15317 Phone: 570-495-0408 | |
Yadavendra S. Rajawat, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 160 Gallery Dr, Canonsburg, PA 15317 Phone: 724-260-7400 Fax: 724-260-7410 |